[PHARMA] QoQ Cumulative Quarter Result on 31-Mar-2013 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
15-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Mar-2013 [#1]
Profit Trend
QoQ- -59.86%
YoY- -13.64%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 1,946,639 1,378,779 937,972 500,339 1,812,346 1,329,942 903,482 66.58%
PBT 92,997 59,990 46,529 36,924 103,313 99,066 70,573 20.13%
Tax -36,236 -24,496 -15,205 -11,771 -40,108 -28,392 -25,435 26.52%
NP 56,761 35,494 31,324 25,153 63,205 70,674 45,138 16.45%
-
NP to SH 55,200 34,387 30,636 24,771 61,710 69,645 44,398 15.57%
-
Tax Rate 38.96% 40.83% 32.68% 31.88% 38.82% 28.66% 36.04% -
Total Cost 1,889,878 1,343,285 906,648 475,186 1,749,141 1,259,268 858,344 69.00%
-
Net Worth 486,754 473,857 481,681 484,829 471,886 496,623 481,282 0.75%
Dividend
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Div 41,477 25,427 17,661 8,825 41,187 29,420 17,650 76.48%
Div Payout % 75.14% 73.95% 57.65% 35.63% 66.74% 42.24% 39.76% -
Equity
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Net Worth 486,754 473,857 481,681 484,829 471,886 496,623 481,282 0.75%
NOSH 258,911 258,938 258,968 117,676 117,677 117,683 117,672 68.92%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 2.92% 2.57% 3.34% 5.03% 3.49% 5.31% 5.00% -
ROE 11.34% 7.26% 6.36% 5.11% 13.08% 14.02% 9.22% -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 751.85 532.47 362.20 425.18 1,540.10 1,130.10 767.79 -1.38%
EPS 21.32 13.28 11.83 21.05 52.44 59.18 37.73 -31.57%
DPS 16.02 9.82 6.82 7.50 35.00 25.00 15.00 4.47%
NAPS 1.88 1.83 1.86 4.12 4.01 4.22 4.09 -40.35%
Adjusted Per Share Value based on latest NOSH - 117,676
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 135.07 95.67 65.08 34.72 125.75 92.28 62.69 66.58%
EPS 3.83 2.39 2.13 1.72 4.28 4.83 3.08 15.59%
DPS 2.88 1.76 1.23 0.61 2.86 2.04 1.22 77.01%
NAPS 0.3377 0.3288 0.3342 0.3364 0.3274 0.3446 0.3339 0.75%
Price Multiplier on Financial Quarter End Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 -
Price 4.45 4.82 4.49 8.26 8.10 7.55 10.18 -
P/RPS 0.59 0.91 1.24 1.94 0.53 0.67 1.33 -41.74%
P/EPS 20.87 36.30 37.95 39.24 15.45 12.76 26.98 -15.69%
EY 4.79 2.76 2.63 2.55 6.47 7.84 3.71 18.51%
DY 3.60 2.04 1.52 0.91 4.32 3.31 1.47 81.39%
P/NAPS 2.37 2.63 2.41 2.00 2.02 1.79 2.49 -3.23%
Price Multiplier on Announcement Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 -
Price 4.29 4.72 4.66 9.26 7.80 8.25 8.83 -
P/RPS 0.57 0.89 1.29 2.18 0.51 0.73 1.15 -37.28%
P/EPS 20.12 35.54 39.39 43.99 14.87 13.94 23.40 -9.55%
EY 4.97 2.81 2.54 2.27 6.72 7.17 4.27 10.61%
DY 3.73 2.08 1.46 0.81 4.49 3.03 1.70 68.61%
P/NAPS 2.28 2.58 2.51 2.25 1.95 1.95 2.16 3.66%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment